Samuel O'Brient

Samuel O'Brient

Expertise: Global Financial Markets, Macroeconomics and Geopolitics

Education: BA, Economics & Political Science, Sarah Lawrence College; MSc, International Politics, Trinity College Dublin

Awards & Accomplishments: Published in Curlew Quarterly. Quoted in Forbes. Interviewed by Foreign Policy.

About Samuel
Samuel O’Brient is a Reporter for InvestorPlace, where his work focuses primarily on financial markets, global economic trends, and public policy. O’Brient writes a weekly column on recent political news that investors should be following.

From his early days at InvestorPlace, O’Brient found himself drawn to the booming world of electric vehicles and green energy. His coverage of mining and other battery components has made him an expert source for industry publications. During his early years as an Economic Policy Analyst at U.S. Resist News, he gained expertise in international trade as the U.S.-China trade war dominated headlines. This in-depth research and analysis experience helped strengthen his prowess in all things political economy. O’Brient brings this expertise to work with him every day, thoughtfully analyzing how the daily happenings on the Capitol trickle down to Wall Street… and how retail investors can take action to profit.

An experienced journalist, editor, and economic policy analyst, O’Brient has spent his career guided by a deep passion for economic theory and policy. As a financial blogger on TipRanks, he has received 4.6 stars and is ranked in the top 10% of stock pickers.

O’Brient’s work on economic and tech policy has been curated by popular outlets Marker, OneZero and Gen.

He can be reached on LinkedIn and Muck Rack.

Recent Articles

Director Matthew Jacobson Is Betting Big on Datadog (DDOG) Stock

Datadog board member Matthew Jacobson has been buying up DDOG stock in spades. Here's why he may be right to acquire it now.

AMC Stock: Do the AMC Bankruptcy Rumors Hold Water?

A report has raised the possibility that AMC Entertainment is facing bankruptcy. Here's why AMC stock won't overcome its mounting problems.

Why Is Cassava Sciences (SAVA) Stock Up 10% Today?

Cassava Sciences has completed part of an important Alzheimer’s disease treatment trial. Here's why SAVA stock may rise even more soon.

25 Penny Stocks to Sell Before They Die

Wondering which small-cap companies you should offload before 2023? Here are the top picks for penny stocks to sell while you still can.

Why Is NIO Stock Down 5% Today?

Nio is falling today along with most of its EV peers. Here's why today's bad news won't keep NIO stock down for long.